Maria Lattanzi

Employment

• GlaxoSmithKline Biologicals Head, Clinical Research and Development, RDC Italy
  2015 - Present

Education

• Università degli Studi di Genova PhD in Vaccinology
  2006 - 2010
• Università degli Studi di Siena Master in Phytotherapy
  2001 - 2002
• Università degli Studi di Siena PhD in Infectious Diseases
  1996 - 2000
• Università degli Studi di Siena Medicine and Surgery
  1988 - 1994

Projects & Funding

Projects & funding information is unavailable.

Publications (3)

• Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine
  mSphere 2025 DOI: 10.1128/msphere.00898-24
  +Save
• Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up
  Vaccine 2023 DOI: 10.1016/j.vaccine.2023.04.061
  +Save
• Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety Analysis
  Drug Safety 2023 DOI: 10.1007/s40264-022-01242-8
  +Save